title: Long-term beneficial effects of a nifedipine-supplemented immunosuppressive regimen in kidney transplantation.
authors.affiliation: Rogosin Institute, New York, NY, USA.
authors.forename: G T
authors.initials: GT
authors.lastname: Shin
authors.forename: J S
authors.initials: JS
authors.lastname: Cheigh
authors.forename: R R
authors.initials: RR
authors.lastname: Riggio
authors.forename: M
authors.initials: M
authors.lastname: Suthanthiran
authors.forename: W T
authors.initials: WT
authors.lastname: Stubenbord
authors.forename: D
authors.initials: D
authors.lastname: Serur
authors.forename: J C
authors.initials: JC
authors.lastname: Wang
authors.forename: A
authors.initials: A
authors.lastname: Rubin
authors.forename: K H
authors.initials: KH
authors.lastname: Stenzel
mesh_terms: D000328:Adult; D001794:Blood Pressure; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D008297:Male; D009543:Nifedipine / Q000627:therapeutic use*; D015996:Survival Rate
chemical_list: D002121:Calcium Channel Blockers; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D009543:Nifedipine